Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to One Year After Immunization with a Pandemic A/H1N1 Influenza Vaccine in Children 3 to < 9 Years of Age. (Q30412506)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to One Year After Immunization with a Pandemic A/H1N1 Influenza Vaccine in Children 3 to < 9 Years of Age. |
scientific article |
Statements
1 reference
Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to One Year After Immunization with a Pandemic A/H1N1 Influenza Vaccine in Children 3 to < 9 Years of Age. (English)
1 reference
Cynthia Nassim
1 reference
Shane Christensen
1 reference
Dan Henry
1 reference
Sandra Holmes
1 reference
Matthew Hohenboken
1 reference
Niranjan Kanesa-Thasan
1 reference
1 February 2012
1 reference
1 reference
Identifiers
1 reference